chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Metal taste in mouth; A practice administrator was calling about the Pfizer Covid Vaccine 2023-2024 formula; they gave a 5-11 years dose to 20-year-old patient; A practice administrator was calling about the Pfizer Covid Vaccine 2023-2024 formula; they gave a 5-11 years dose to 20-year-old patient; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team.  A 20-year-old female patient received bnt162b2 omi xbb.1.5 (PFIZER-BIONTECH COVID-19 VACCINE (2023-2024 FORMULA)), on 05Oct2023 as dose 1, 0.3 ml single (Lot number: HE2391, Expiration Date: 30Apr2024) at the age of 20 years intramuscular, in left deltoid for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), UNDERDOSE (non-serious) all with onset 05Oct2023, outcome "unknown" and all described as "A practice administrator was calling about the Pfizer Covid Vaccine 2023-2024 formula; they gave a 5-11 years dose to 20-year-old patient"; DYSGEUSIA (non-serious) with onset 05Oct2023, outcome "unknown", described as "Metal taste in mouth". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: A practice administrator was calling about the Pfizer Covid Vaccine 2023-2024 formula; they gave a 5-11 years dose to 20-year-old patient and wanted to see what was recommended. Caller stated that she called about the Covid vaccine 5-11, a Pfizer product. They had determined doing a vaccine inventory that they gave a 5-11 dose to a 20 year old. Knew they got a weaker dose. Wanted to know was it recommended to do second one or leave with the dose they got. Clarified name of the product as it appeared on the label as the Pfizer Biontech Covid 19 vaccine 2023-2024 formula (for ages 5 years to less than 12). Was a few weeks that determined that this happened. They do need to notify the patient if they had to come back in.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.  Follow-up (27Oct2023): This is a spontaneous follow-up report received from a contactable Nurse. Updated information Included: Reporter information added and new reporter in sliders 2 and 3 added. Updated Slider 1 as an HCP. Patient (Date of birth, Height and weight) added. For suspect dose date, Dose, Unit, Lot, Expiration date and Dose description updated. New event of Dysgeusia and additional information updated.
After receiving flu shot, I got in car to drive home, and began to have some facial numbness, tingling, increased weakness. I turned back around and had 4 episodes of diarrhea. I then went to ER and was evaluated and treated as possible adverse reaction vs allergic reaction to flu shot. Had further episodes of diarrhea. Tachycardic upon ER evaluation and continued tachycardia. Treated with IM BENADRYL and sent home. Have continued to have upset stomach, diarrhea, facial numbness/tingling, tachycardia.
Typical arm soreness right after the shot. The next morning however, a severe headache that lasted most of the day and the soreness was more pronounced - treated with Advil II.
The patient received the Pfizer BIValent Booster with only 1 vaccine in the primary series  No adverse events
With both COVID vaccines pt experienced raspy voice, hoarseness, funny feeling in bronchial tubes.  Pt denies SOB, CP or anaphylaxis.  Her symptoms started approximately 1 hour after admin and resolved within 3 hours of onset.
About 3 days after shots, client felt mild bone pain in back, which spread over time to feet, hands, legs, arms, & throughout body.  Pain also worsened.  She called the LHD about 1 week after the shots & was told it was not from the shots.  She went to her doctor.  The nurses there said it was not from the shots, but the doctor said it was definitely arthritis from the shots and probably from having A & B together.  He put her on Vioxx & it took her about 3 weeks to improve.  She had the 2nd Hep B, with reservations, on 6/26/01 (same manufacturer & lot#) at the same health dept.  The nurses there told her to take Vioxx again if symptoms recurred.  Client had the same reaction, but milder, and took Vioxx again.  Second HepA (Merck, #0244L) & third HepB (GSK, #5236A4) given on 12/3/01.  Pain worsened during winter (client stated probably due to the cold), and decreased with warmer weather.  Currently, pain comes & goes in her back, but persists in her L hand so that she can't grip anything with that hand.  Client now takes Advil as needed, which is "quite often."  Pain worsens with activity, such as yard work.  Knees have not been affected.  Client also experienced "pretty bad nausea" after first set of shots. (NOTE: Injection sites listed in #13 may be opposite, but one shot was given in each arm). The 60 day follow-up states that the client states currently she is doing "quite well" and is without pain. However the pain in her L hand persisted quite badly throughout July 2002. Pain "flare up" with weather/barometer changes. She is concerned about how it will feel in the upcoming winter weather.
On 4/16/21 patient reported the following: "I have been experiencing dizziness, being really tired and then when I try to go to sleep I cannot go to sleep, and being able to focus". States symptoms started around 11am on 4/8/21 after receiving the vaccine that morning at 9:45am. As of 4/19 her symptoms were improving.
Patient received dtap left thigh intramuscularly and IPV left thigh intramuscularly on 08/29/2005.  On 09/01/2005 patient was assessed by doctor to have local reaction to vaccine left anterior thigh with large red macular lesion.  Benadryl with cool compresses were recommended.
Patient began feeling dizzy approximately 2 minutes after vaccination. Blood pressure 177/98, HR 145 bpm, O2 sat 99%. Patient observed.
Vaccine Tuesday 6 PM Wednesday Afternoon, sore arm, neck, upper back.  As the day went on, felt very flushed, hot ears, felt flu-ish, lower back pain.  Temperature of 100.9. Thursday, small lump above collar bone, sore to touch.   Friday Migraine and nausea, lump going down in size. Saturday, slight headache, symptoms gone by end of day.
This spontaneous report was received from a healthcare worker refers to an unspecified patients of unknown age. On an unknown date, the patients were vaccinated with an improperly stored PROQUAD (Merck) (lot#K006117, expiry date 14-JAN-2017, lot # L007230, expiry date 03-SEP-2016, lot # K025761, expiry date 08-JUN-2016). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
approx 30hr p/vax pt felt hot (no temp documented) went limp briefly x2 then 3 short shakes of body-pt seemed awake during this no definite sz activity but possible paramedics called examined;no further problems;
This spontaneous report as received from an unknown source refers to an 12 year old female patient. The patient's medical history included vaccination with DTAP (unspecified), hepatitis A virus vaccine (unspecified), hepatitis B virus vaccine (unspecified), Hib conj vaccine (unspecified carrier), influenza virus vaccine (unspecified), M-M-R vaccine, pneumococcal vaccine (unspecified), poliovirus vaccine inactivated (unspecified) and varicella virus vaccine (unspecified). On 02-DEC-2014, the patient was vaccinated with first dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) vaccine (manufacturer unknown) (dose, anatomical location and lot# was not reported), influenza virus vaccine (unspecified) (4th dose, dose, anatomical location and lot# was not reported), meningococcal vaccine (unspecified) (1st dose, dose, anatomical location and lot# was not reported) and diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (1st dose, dose, anatomical location and lot# was not reported). On an unknown date the patient experienced lethargy, fever like symptoms (chills, flushed face but temperature equal to 1 degree lower than 97, absence seizures, tendon aches, headache, stomach ache, nausea, leg numbness from knee to down, tingling, sore throat (with a taste of blood) and itchy/tingly skin. The outcome the events was unknown. The causal relationship between the events and the suspect therapies was not reported. Additional information has been requested.
A hard red lump formed at injection site pt spiked a low grade fever, nausea, and malaise - redness spread overnight 24 hrs all over the arm and then after another 12 to 24 hrs it subsided and pt is now feeling a lot better but still following up with the pcp.
Had bout of shivering; Slight fever; This case was reported by a consumer and described the occurrence of shivering in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th January 2021, the patient received the 2nd dose of Shingrix. In January 2021, less than a day after receiving Shingrix, the patient experienced shivering and fever. On an unknown date, the outcome of the shivering and fever were unknown.   It was unknown if the reporter considered the shivering and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had overnight bout of shivering and slight fever.
Angioedema Urticaria Symptoms occurred several hours after vaccine admin. Treated with diphenhydramine.
Two days after I received my first vaccine, horrible pulsating, loud tinnitus  started.  A loud ringing in my right ear with every heart beat.  I couldn't sleep for many days and still have trouble after all this time.   The pulsating is non stop... 24/7.   I am doing my best to live with this but it is unbearable at times, to the point of driving me close to insanity.  I have some days where it is bearable, but never goes away.  I would have never gotten the covid-19 shot had I known that the adverse effect would have been this bad.   I has all but ruined my way of life up to this point.
Total paralysis from Guillain-Barre syndrome requiring intubation, tracheostomy, ventilator for 60 + days, extreme pain. Received IV/IG transfusions. Can now move & walk, but legs & feet remain weak & painful. Left side of face droops, left eye is blurry. Cannot walk or stand for extended periods.
COVID; COVID; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient received BNT162b2 (BNT162B2), on 17Mar2021 as dose 2, single (Lot number: ER2613) at the age of 74 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: DILAUDID ATROPIN taken for knee arthroplasty; MAXZIDE taken for hypertension. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID". Patient had COVID and they told her she had to wait 3 months before she could get the booster. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: I did have COVID.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201282571 same patient different dose/drug/event;
Severe rash in left underarm, requires topical steroid. Menstrual cycle 3 days late.  Rash appeared within a couple days of second dose. Has not gone away.
15 minutes after receiving vaccine, patient report left ear turning red. Patient waited in the clinic an additional 30 minutes. Left ear was red and patient report left arm and neck felt warm. Patient was seen by a provider who recommended she take an oral Benadryl and report to the ER if any other anaphylaxis reactions.
10/06/2005 3:50 placed call to pts # listed. Spoke to patients grandfather. Grandfather states he's fine, no problems. Younger voice on phone (child) stated he's ok, listening on other phone. Explained vaccine to grandfather. No adverse reaction.
pt recv vax 22OCT96 & 20NOv96 pt had rt leg pain & swelling of the rt knee;pt was dx w/juvenile rt knee arthritis;blood work & x-rays were done;MD noted the event occurred subsequent to vax but they were not stating it was adverse rxn sure
Patient states after receiving immunizations on 3/28/14 in afternoon began having localized pain in right arm that has spread from head to down right leg with pain progressively getting worse. States took Ibuprofen with little relief of pain. Had allergy shots same day as immunizations.
Maculopapular rash to chest back, greatest on L side no fever/chills. Does report mild headache x 1 day. No other complaints.
21AUg97 urinary frequency began;was up 1hr on 22AUG devel severe h/a & extreme fatigue;saw PMD & urologist @ med school;blood sugar 66 low;dec appetite;
Myocarditis; This is a spontaneous report from a non-contactable consumer.   An 8-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on Nov2021, at the age of 8-years-old, (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient received Pfizer vaccine and was in ICU with myocarditis within 2 days (unspecified day of Nov2021). He was "totally healthy and active" prior to vaccination. The outcome of the event was unknown. Treatment was received for the events.  The lot number for (BNT162B2), was not provided and will be requested during follow-up.
Injection site pain, shivering, nausea or just general malaise feeling, headache. I got a mild red spot rash across my chest area after the first shot. Too soon to  know if that will happen again. I do not remember feeling poorly after the first shot like I feel today
10 days post vax devel rash-full body sandpaper feeling macular papular rash lasting 2 1/2wk w/peeling-very pruritic-no conjunctival or oral involvement;no fevers, pain-rash now resolving;
(5/26/2021 & 07/01/2021)UTI, Epididymitis course of antibiotics,(1st course) Sulfamethlzole-TMP DS (2nd course) ER visit Ciprofloxacin HCL (7/11/2021 resolved)
I began to get more frequent migraines than I've had in the past few years since I received the booster.
Chest pain, itching from my head to top of my feet.  Lightheaded and when I focus everything words run together.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer. This consumer reported similar events for himself and his wife. This is the second of two reports. A female patient (consumer's wife) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose via an unspecified route of administration, administered in arm left on 30Jan2021 13:00 (lot number: EL9264) as single dose, second dose via an unspecified route of administration, administered in arm left on 20Feb2021 12:45 (Lot Number: EL9266) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The consumer reported that the patient was tested positive for the COVID virus after receiving the 2nd dose on 05Apr2021. Event resulted in physician office visit. No covid test prior vaccination. Covid tested post vaccination on 05Apr2021: covid test type post vaccination was nasal swab, covid test name post vaccination was antigen and polymerase chain reaction (PCR), with result positive. Therapeutic measures were taken as a result of event tested positive for the COVID virus after receiving the 2nd dose. The event outcome was recovered on an unknown date in 2021.; Sender's Comments: Linked Report(s) : PFIZER INC-2021523894 Same reporter, event, vaccine/different patient
Initial unsolicited report received on 20 November 2014 from a consumer who is the patient. A 51 year old female patient, date of birth not reported, was vaccinated on an unspecified date in 2012 with INFLUENZA, batch number, route and site of administration were not reported. The patient's medical history and concomitant medications were not reported. The patient experienced an unspecified severe inflammatory response on an unreported date in 2012. Laboratory tests were not reported. The patient required 7 weeks of physician therapy and states that a VAERS was filed in 2012. The patient outcome is recovered on an unreported date. Documents held by sender: None.
Resident of nursing home with numerous underlying conditions. Patient received his first dose of Pfizer through pharmacy at the nursing home2/15/2021, Dose 2 was 5/13/2021,  The Health Department was unaware of dose 1. Staff called the Health Department requesting dose 2 on June 18, 2021. We discovered the error when we checked the system. I called the facility and they informed me that their infectious disease specialist said they had to administer another dose of the vaccine because dose 1 and 2 were too far apart. I sent them CDC guidance correcting this assertion.  The resident has suffered no adverse effects.
Developed shooting pain in left elbow during the night post receiving flu shot earlier. Limited movement of arm due to elbow pain. Has full range of motion/no numbness or tingling but achiness at end of day.
Very painful after the shot. This is the first time I had the high dose flu shot- never had a problem with the other flu shots that I've had for years. Two days later had a very red rash around where the shot was given- had about a two inch radius. I called the pharmacist who told me to circle the rash and seek medical help if it spreads. It lessened after 3 days but very scary to see.
UPON ADMINISTRATION OF VACCINATION THE AREA TURNED RED AND STARTED SWELLING. PT HAD A GOLF BALL SIZED KNOT AT SITE OF INJECTION WITH REDNESS AND NO OTHER SYMPTOMS.
pt had vax on 11JAN93 mom called on 12JAN93 stated rt leg was sore & stiff; 13JAN93 pt's temp 105 & febrile convuls; mom took to ER; 15JAN93 mom took pt to MD t103;
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 12-month-old patient of unknown gender. On 08-MAR-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and a dose of VARIVAX lot number N027002 (expiration date: 28-SEP-2019) (doses, routes and anatomical locations of administration were not provided for both vaccines) for prophylaxis. This is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-1807USA011661:
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 15-FEB-2019, the patient was vaccinated with improperly stored PEDVAXHIB (1 injection, via intramuscular, lot # reported as: R0123571, expiration date: 19-MAR-2021; strength and anatomical location were not reported) for prophylaxis. No adverse effect was reported. The PEDVAXHIB was exposed to 0 degree Celsius for 45 minutes. There was no previous temperature excursion. The data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1902USA008818: US-009507513-1903USA006922: US-009507513-1903USA006923: US-009507513-1903USA006924: US-009507513-1903USA006925: US-009507513-1903USA006926: US-009507513-1903USA006927: US-009507513-1903USA006928: US-009507513-1903USA006929: US-009507513-1903USA006930: US-009507513-1903USA006931: US-009507513-1903USA006932:  US-009507513-1903USA006933: US-009507513-1903USA006934: US-009507513-1903USA006935: US-009507513-1903USA006936: US-009507513-1903USA006937: US-009507513-1903USA006938: US-009507513-1903USA006939: US-009507513-1903USA006940: US-009507513-1903USA006941: US-009507513-1903USA006942: US-009507513-1903USA006943: US-009507513-1903USA006944: US-009507513-1903USA006945: US-009507513-1903USA006946: US-009507513-1903USA006947: US-009507513-1903USA006948: US-009507513-1903USA006949.
Patient came in for a shingles shot and was accidently given a covid Pfizer vaccine instead.
11 days after the 3rd Moderns booster, Patient began experiencing severe whole body itching and hives. They have since lasted for 3 more days and is ongoing. Allegra helps reduce itching but wears off the next day. Visited a dermatologist who prescribed antihistamines for 2 weeks.
1wk post vax-pt exp sz-encephalopathy-16 days in hosp;
Received expired doses of the Moderna COVID vaccine; Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022). On 17-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter.  It was reported that the vaccines were placed in refrigerator on 13-Jan-2022. Expiration date placed on vial was12-Feb-2022.  No treatment medication was reported by the reporter.
Pt was admitted to the hospital due to complications of known  Follicular lymphonma.  She tested positive for COVID on routine admission testing.  She had history of previous COVID positive with monoconal antibody treatment
COUGH, SOB, RASH, RUNNY NOSE, CONGESTION, HEADACHE, CHEST CONGESTION, CHANGE IN SMELL, FATIGUE.